Posts Tagged ‘
Biotech Stocks ’
Jul 1st, 2009 |
By Marc Lichtenfeld |
Category: Featured, Stock Market Investing
There are a number of health care reform plans on the drawing boards right now, and they all seem to come with mind-numbing sticker shock. The administration’s new plan and Senator Kennedy’s plan are both estimated to cost $1 trillion over 10 years.
Tags: Biotech Stocks, Bond Funds, GENZ, Marc Lichtenfeld, RRPIX, TBT, TEVA, WPI
Posted in Featured, Stock Market Investing |
No Comments »
Jun 18th, 2009 |
By Marc Lichtenfeld |
Category: Featured, Stock Market Investing
Both President Obama’s and Senator Kennedy’s healthcare plans are estimated to cost $1 trillion over 10 years. I’ll believe it when I see it. When was the last time the government completed any project on budget?
Tags: Biotech Stocks, Bond Market, Bond Prices, GENZ, Healthcare Reform, Marc Lichtenfeld, RRPIX, TBT, TEVA, U S Treasury, WPI
Posted in Featured, Stock Market Investing |
No Comments »
Mar 24th, 2009 |
By Marc Lichtenfeld |
Category: Stock Market Investing, Top Story
With so many biotech stocks making big moves and pharmaceutical merger activity moving faster than anything else right now, we turned to one of the smartest analysts in the lucrative biotech field to give us his take on what we should be doing…
Tags: Amgen, Big pharma, Biotech Sector, Biotech Stocks, gilead sciences, Marc Lichtenfeld, Pfizer, Pharmaceutical Merger, Small Cap
Posted in Stock Market Investing, Top Story |
No Comments »
Mar 13th, 2009 |
By Martin Denholm |
Category: Featured
Talk about a winter of discontent… Over the past seven weeks, we’ve seen quite possibly one of the best examples of stock market fear in history.
Tags: AMGN, BIIB, Biotech Stocks, BMRN, CVTX, DNA, GENZ, GILD, investment advice, JPM, Loan Commitments, Marc Lichtenfeld, MDVN, MRK, Pfe, Sgp, WYE
Posted in Featured |
No Comments »
Mar 6th, 2009 |
By Marc Lichtenfeld |
Category: Financial News
Tune into the financial media and you’re guaranteed to hear an “expert” call the stock market’s bottom at least once a day.
Tags: American Association Of Individual Investors, BA, bear market, Biotech Stocks, Bmy, Consumer Confidence Index, GS, Investor Confidence, Marc Lichtenfeld, Market Rally, Stock Market, Us Stock Market
Posted in Financial News |
No Comments »
Feb 5th, 2009 |
By Laura Cadden |
Category: Featured
After the 2001 anthrax attacks on government and media figures, no one wanted to take chances. In the worst biological attack in U.S. history, five people died and another 17 were infected. But what of future potential victims who don’t have such diligent facilities managers at their places of work and do come in contact with anthrax spores? TFN eNews reader and Hot Stock Confidential member John H. turned me on to a tiny outfit that addresses this deadly aspect of anthrax exposure.
Tags: Anthrax Attacks, Biotech Stocks, HGSI, Human Genome Sciences, Laura Cadden
Posted in Featured |
No Comments »
Jan 30th, 2009 |
By Marc Lichtenfeld |
Category: Stock Market Investing
It wasn’t too long ago that a bad bank just meant one with long lines, rude tellers and high fees. But times are changing and the definition today is completely different.
Tags: Biotech Stocks, DNA, Financial Sector, healthcare sector, Marc Lichtenfeld, Obama, Pfe, US Banking, WYE
Posted in Stock Market Investing |
1 Comment »
Jan 16th, 2009 |
By Marc Lichtenfeld |
Category: Financial News
“Yes we can,” as incoming president Barack Obama famously declared in his presidential victory speech. Head down the road to The Capitol and we’ll need to modify that to, “Yes, we might,” as lawmakers in Congress debate an $825 billion economic stimulus package.
Tags: ARAY, BAC, Barack Obama, Bernanke, Biotech Stocks, Citigroup, DNA, ECB, Financial Bailout, Marc Lichtenfeld, Martin Denholm, MDVN, Pennies
Posted in Financial News |
No Comments »
Jan 13th, 2009 |
By Laura Cadden |
Category: Top Story
Biotech companies are a great investment right now, says Laura Cadden. And support from the Obama administration will ensure this trend continues. Laura picks four small cap biotech firms set to soar.
Tags: ASTM, bear market, Biotech Stocks, biotechnology, CERS, credit crisis, CYTX, GERN, Laura Cadden, MRK, Obama administration, Penny Stocks, President Obama, Small Caps, stock market investing, US stocks
Posted in Top Story |
1 Comment »
Dec 19th, 2008 |
By Laura Cadden |
Category: Financial News
Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) is a biopharmaceutical company that focuses entirely on RNA-based technologies and primarily, on antisense therapies.
Tags: ABT, Antisense Drugs, Biotech Stocks, ISIS, Laura Cadden, Novartis
Posted in Financial News |
No Comments »